$241.71+40.22% · 3M
Moving avg
1W+3.99%
1M+16.30%
3M+41.62%
6M+43.15%
YTD+7.25%
1Y+27.06%
3Y+9.81%
5Y-2.59%
52-week range
$154.5094% of range$247.05
Company health
Value2/6
Growth4/6
Profitability3/6
Health1/6
Dividend0/6
Bull vs bear
Strengths
- Analyst consensus is "Buy"
- High return on equity (2246%)
- Revenue compounding 10% a year
Risks
- Highly leveraged (debt is 2.5x equity)
Key statistics
Valuation
Market cap
$39.79B
Enterprise value
$49.19B
P/E ratio (TTM)
25.82x
P/S ratio (TTM)
2.11x
EV/EBITDA
13.98x
Per share & returns
EPS (TTM)
$8.22
Dividend yield
0.00%
Beta (1Y)
1.20
30-day change
+16.30%
Trading
Volume (24h)
0
Previous close
$243.84
Shares outstanding
164.60M
About IQVIA Holdings Inc.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Exchange
NYSE
Symbol
IQV
IQVIA Holdings Inc. is a large-cap healthcare company in the Medical - Diagnostics & Research industry. Its shares are listed on NYSE (United States) and trade under the ticker IQV.
Frequently asked questions
What is IQVIA Holdings Inc.'s market cap?
IQVIA Holdings Inc. (IQV) has a market capitalization of $39.79B.
What is IQVIA Holdings Inc.'s P/E ratio?
IQVIA Holdings Inc. trades at a price-to-earnings (P/E) ratio of 25.82.
What exchange does IQV trade on?
IQV trades on NYSE.
Appears in
Eli Lilly and CompanyLLY
$1,220.51+0.45%
$1.15T cap
Johnson & JohnsonJNJ
$260.86+0.41%
$628.65B cap
AbbVie Inc.ABBV
$248.66-0.57%
$439.33B cap
UnitedHealth Group IncorporatedUNH
$405.59+0.85%
$368.33B cap
Roche Holding AGSWX: ROP
CHF 365.50-0.92%
$357.62B cap
Merck & Co., Inc.MRK
$132.93+1.92%
$328.31B cap
Novartis AGSWX: NOVN
CHF 124.20-1.32%
$290.17B cap
AstraZeneca PLCLON: AZN
£117.02-1.20%
$244.86B cap